Compare TOST & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOST | FMS |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | United States | Germany |
| Employees | N/A | 108165 |
| Industry | EDP Services | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 12.5B |
| IPO Year | 2021 | N/A |
| Metric | TOST | FMS |
|---|---|---|
| Price | $28.88 | $23.52 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 22 | 2 |
| Target Price | ★ $41.29 | $30.00 |
| AVG Volume (30 Days) | ★ 12.5M | 591.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | ★ 1766.67 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $6,153,000,000.00 | N/A |
| Revenue This Year | $22.69 | N/A |
| Revenue Next Year | $18.03 | $3.83 |
| P/E Ratio | $143.38 | ★ $15.62 |
| Revenue Growth | ★ 24.05 | N/A |
| 52 Week Low | $22.26 | $20.02 |
| 52 Week High | $49.66 | $27.64 |
| Indicator | TOST | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 67.37 | 59.27 |
| Support Level | $24.42 | $23.50 |
| Resistance Level | $30.36 | $23.91 |
| Average True Range (ATR) | 1.06 | 0.34 |
| MACD | 0.50 | -0.03 |
| Stochastic Oscillator | 94.32 | 73.17 |
Toast Inc is a cloud-based, all-in-one digital technology platform purpose-built for the restaurant community. The company provides a comprehensive platform of software-as-a-service (SaaS) products and financial technology solutions, including integrated payment processing, restaurant-grade hardware, and a broad ecosystem of third-party partners. It serves as a restaurant operating system, connecting front of house and back of house operations across service models such as dine-in, takeout, and delivery. It operates through one reportable segment consisting of its SaaS products, financial technology solutions, integrated payments, hardware, and partner ecosystem.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.